Murray A. Raskind, Director | NW MIRECC - MIRECC / CoE
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

MIRECC / CoE

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Murray A. Raskind, Director | NW MIRECC

Murray A. Raskind, M.D., Director, Mental Illness Research, Education and Clinical Center

Murray A. Raskind, M.D.

Director, Mental Illness Research, Education and Clinical Center, VA Puget Sound Health Care System;
Professor and Vice-Chairman, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine and Director, Alzheimer's Disease Research Center, University of Washington School of MedicineMurray A. Raskind, M.D.

Dr. Murray Raskind received his BA degree from Brown University and his MD degree from Columbia University College of Physicians and Surgeons. He completed internal medicine residency at the Columbia Harlem Hospital Center and subsequent psychiatry residency at the University of Washington. Dr. Raskind currently is Professor of Psychiatry and Behavioral Sciences at the University of Washington and directs the Veterans Affairs Northwest Network (VISN 20) Mental Illness Research, Education, and Clinical Center (MIRECC).  Dr. Murray Raskind's past leadership positions include: Director of the Geriatric Research Education and Clinical Center (GRECC) at VA Puget Sound, Associate Chief of Staff for Mental Health at VA Puget Sound, and Director of the University of Washington Alzheimer’s Disease Research Center.

Research:  Dr. Murray Raskind discovered that prazosin, an antiadrenergic drug originally developed to treat hypertension, is effective for combat PTSD trauma nightmares, sleep disruption and daytime hyperarousal symptoms. Current research efforts address a precision medicine approach to prescribing prazosin for PTSD, and expanding prazosin indications to alcohol use disorder, post-concussion migraine headache, and disruptive agitation in Alzheimer’s disease. Dr. Raskind was presented the 2011 John B. Barnwell Award for Outstanding Achievement in Clinical Science by the Department of Veterans Affairs Office of Research and Development.